16 June 2017Insurance

SCOR enters US medical reinsurance market

SCOR Global Life, the international life and health subsidiary of French reinsurer SCOR, has entered the US medical reinsurance market, offering a portfolio of customised solutions to manage medical risk and complex claims.

SCOR’s medical reinsurance operation is based in Minneapolis. It is supported by the actuarial, underwriting and medical director resources in Leawood, Kansas and Charlotte, North Carolina. The business is underwritten by General Security National Insurance Company (GSNIC).

The company’s initial product lines include reinsurance coverage for Health Medical Organisations (HMOs) and insurance companies. As it obtains necessary regulatory approvals, SCOR will offer provider excess and employer stop loss insurance, according to a statement.

"We are a market leader in US life reinsurance and an established player in the group life market here,” said Paolo De Martin, CEO of SCOR Global Life. "The adjacent medical market offers a substantial opportunity to expand our US footprint."

"This is a large market with significant demand for risk management solutions and expertise,” he said. “We made a comprehensive study of its potential and we believe we can effectively and successfully support the needs of existing and emerging market participants."

The company stated that it has assembled a team of senior executives from within to manage the new unit. Kelly Munger was the first executive hire, it added.

"When we made the strategic decision to enter the market, we knew we needed an A-team of health care and risk management experts to develop a business plan, build out a first-rate organisation and make an immediate impact in the medical excess market," said JC Brueckner, CEO of SCOR Global Life in the Americas.

“[Munger] leads our Group Reinsurance business unit and has done a superb job assembling a team of experienced professionals who understand the changes occurring in the market and who will work with brokers to develop customized solutions for their clients."

Munger commented: "The medical market is complex and evolving. SCOR may be a new player but everyone on the team has worked in the health care industry for many years and their expertise allows them to navigate the changes that are occurring. We have a strong sense of purpose and are intently focused on high performance and client satisfaction."

Today’s stories

Arch Re replaces Canadian CEO with Aon Benfield executive

R&Q completes $46.5m loss portfolio transfer

Willis Towers Watson bolsters insurance risk unit with new hire

Novae strengthens marine unit with Everards hire

Admiral breached new FCA renewal rules

Australian Reinsurance Pool names new chair

Zurich private clients head joins Munich Re-backed MGA UK General

New alliance to drive blockchain use in insurance broker market

Charles Taylor appoints non-executive director

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories like this sent straight to your inbox.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Insurance
1 September 2017   Ratings agency AM Best said on September 1 that it has upgraded the Financial Strength Ratings (FSR) to A+ (Superior) from A (Excellent) of SCOR and its main operating subsidiaries citing its operating strength as a driver for the move.
News
24 August 2017   Following regulatory approval, French reinsurer SCOR said on Aug. 24 that it is opening a SCOR Global P&C SE representative office in Nairobi, Kenya.
Insurance
17 July 2017   French reinsurer SCOR has signed an agreement with the Fédération nationale de la Mutualité Française and Matmut to acquire 100 percent of the shares of MutRé.